$1.02 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 56 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 21.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $57,740,000 | +34.9% | 925,170 | +24.5% | 5.67% | +28.2% |
| PFE | Buy | PFIZER INC | $57,366,000 | +36.6% | 1,693,707 | +42.1% | 5.63% | +29.9% |
| CELG | Buy | CELGENE CORP | $50,396,000 | +22.6% | 482,118 | +15.7% | 4.95% | +16.6% |
| LLY | Buy | ELI LILLY & CO | $48,752,000 | +16.8% | 607,427 | +14.6% | 4.79% | +11.1% |
| MDT | Buy | MEDTRONIC PLC | $45,035,000 | +22.0% | 521,241 | +22.5% | 4.42% | +16.0% |
| GILD | Buy | GILEAD SCIENCES INC | $41,472,000 | +4.4% | 524,165 | +10.1% | 4.07% | -0.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES | $40,663,000 | -11.6% | 802,979 | -20.7% | 3.99% | -16.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $38,055,000 | -1.2% | 411,317 | -16.9% | 3.74% | -6.0% |
| ABMD | Sell | ABIOMED INC | $32,627,000 | +0.1% | 253,745 | -14.9% | 3.20% | -4.9% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $32,230,000 | +11.1% | 1,419,208 | +15.4% | 3.16% | +5.6% |
| SHPG | Buy | SHIRE PLCsp adr | $32,199,000 | +17.9% | 166,093 | +11.9% | 3.16% | +12.1% |
| FOLD | Sell | AMICUS THERAPEUTICS | $31,039,000 | +18.7% | 4,194,452 | -12.4% | 3.05% | +12.9% |
| NXTM | Sell | NXSTAGE MEDICAL | $29,985,000 | -24.4% | 1,199,869 | -34.4% | 2.94% | -28.1% |
| ACHC | Buy | ACADIA HEALTHCARE | $28,579,000 | +7.3% | 576,769 | +20.0% | 2.80% | +2.0% |
| TDOC | Buy | TELADOC INC | $28,190,000 | +20.2% | 1,539,618 | +5.1% | 2.77% | +14.2% |
| DXCM | Sell | DEXCOM INC | $28,183,000 | -9.9% | 321,502 | -18.5% | 2.77% | -14.4% |
| CI | New | CIGNA CORP | $28,029,000 | – | 215,080 | +100.0% | 2.75% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $23,775,000 | +45.2% | 1,031,449 | +4.5% | 2.33% | +38.0% |
| ALGN | Sell | ALIGN TECH INC | $22,748,000 | +14.7% | 242,641 | -1.4% | 2.23% | +9.1% |
| INCY | Sell | INCYTE CORPORATION | $21,089,000 | +6.1% | 223,663 | -10.0% | 2.07% | +0.9% |
| TEVA | Sell | TEVA PHARMACEUTICALadr | $20,896,000 | -32.5% | 454,172 | -26.3% | 2.05% | -35.8% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $20,523,000 | +61.0% | 28,314 | +46.9% | 2.02% | +53.1% |
| VRTX | Sell | VERTEX PHARMACEUTICALS | $19,001,000 | -4.6% | 217,874 | -5.9% | 1.86% | -9.3% |
| NVO | Buy | NOVO-NORDISK ASadr | $18,523,000 | +59.3% | 445,375 | +106.0% | 1.82% | +51.4% |
| OPHT | Buy | OPHTHOTECH CORP | $17,961,000 | +139.8% | 389,363 | +165.2% | 1.76% | +127.8% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS | $17,601,000 | +34.2% | 537,121 | +2.3% | 1.73% | +27.6% |
| XLRN | Sell | ACCELERON PHARMA | $17,435,000 | -1.8% | 481,765 | -7.8% | 1.71% | -6.7% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL | $13,595,000 | +289.7% | 705,845 | +139.8% | 1.34% | +270.8% |
| WMGI | Buy | WRIGHT MED GROUP N V | $12,388,000 | +94.4% | 505,005 | +37.6% | 1.22% | +84.8% |
| NUVA | Buy | NUVASIVE INC | $11,996,000 | +20.8% | 179,960 | +8.2% | 1.18% | +14.9% |
| ARAY | Buy | ACCURAY INC | $11,814,000 | +175.6% | 1,854,625 | +124.6% | 1.16% | +161.9% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS | $11,628,000 | +49.1% | 70,651 | +29.3% | 1.14% | +41.7% |
| PTCT | Buy | PTC THERAPEUTICS I | $10,928,000 | +139.9% | 779,998 | +20.2% | 1.07% | +128.3% |
| AERI | Buy | AERIE PHARMACEUTICALS | $9,405,000 | +504.4% | 249,200 | +181.9% | 0.92% | +473.3% |
| MOH | Buy | MOLINA HEALTHCARE | $8,931,000 | +17.1% | 153,145 | +0.2% | 0.88% | +11.3% |
| PRTA | Sell | PROTHENA CORP PLC | $7,433,000 | +21.7% | 123,946 | -29.1% | 0.73% | +15.7% |
| KITE | New | KITE PHARMA INC | $6,498,000 | – | 116,326 | +100.0% | 0.64% | – |
| AMSG | Buy | AMSURG CORP | $6,474,000 | -13.4% | 96,560 | +0.2% | 0.64% | -17.6% |
| TMH | Buy | TEAM HEALTH HOLDINGS | $6,042,000 | -15.5% | 185,560 | +5.5% | 0.59% | -19.8% |
| AVXS | Buy | AVEXIS INC | $6,038,000 | +518.6% | 146,515 | +470.7% | 0.59% | +487.1% |
| IART | Buy | INTEGRA LIFESCIENCE | $5,712,000 | +18.2% | 69,200 | +14.3% | 0.56% | +12.4% |
| SCAI | SURGICAL CARE AFFILIATES | $4,793,000 | +2.3% | 98,300 | 0.0% | 0.47% | -2.9% | |
| ADXS | Buy | ADVAXIS INC | $4,668,000 | +33.0% | 436,659 | +0.6% | 0.46% | +26.5% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS | $4,149,000 | -33.1% | 354,900 | -38.2% | 0.41% | -36.4% |
| RGNX | Sell | REGENXBIO INC | $3,221,000 | -4.7% | 243,613 | -33.7% | 0.32% | -9.5% |
| Buy | NEURODERM LTDordinar | $2,995,000 | +75.6% | 161,971 | +54.3% | 0.29% | +67.0% | |
| ENTL | Sell | ENTELLUS MED INC | $2,963,000 | +11.1% | 133,596 | -8.5% | 0.29% | +5.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS | $2,784,000 | +84.1% | 52,700 | +46.0% | 0.27% | +75.0% |
| XENT | Sell | INTERSECT ENT INC | $2,663,000 | +6.6% | 168,140 | -12.9% | 0.26% | +1.2% |
| LCI | Sell | LANNETT CO INC | $2,330,000 | -4.6% | 87,693 | -14.6% | 0.23% | -9.1% |
| NTLA | INTELLIA THERAPEUTICS | $2,320,000 | +58.3% | 123,159 | 0.0% | 0.23% | +51.0% | |
| ACAD | Buy | ACADIA PHARMACEUTCALS | $1,778,000 | +85.2% | 55,897 | +89.0% | 0.18% | +76.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS | $1,749,000 | +215.1% | 25,800 | +158.0% | 0.17% | +201.8% |
| RDY | DR REDDYS LABS LTDadr | $1,493,000 | -9.4% | 32,155 | 0.0% | 0.15% | -13.5% | |
| DBVT | New | DBV TECHNOLOGIESsp adr | $1,428,000 | – | 39,301 | +100.0% | 0.14% | – |
| DNAI | PRONAI THERAPEUTICS | $399,000 | -70.6% | 201,660 | 0.0% | 0.04% | -72.1% | |
| PRFMF | Exit | PROFOUND MEDICAL | $0 | – | -541,500 | -100.0% | -0.06% | – |
| MCRB | Exit | SERES THERAPEUTICS | $0 | – | -20,600 | -100.0% | -0.06% | – |
| CBPO | Exit | CHINA BIOLOGIC PROD | $0 | – | -5,890 | -100.0% | -0.06% | – |
| SAGE | Exit | SAGE THERAPEUTICS | $0 | – | -52,250 | -100.0% | -0.16% | – |
| QURE | Exit | UNIQURE N.V. | $0 | – | -347,271 | -100.0% | -0.26% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -912,305 | -100.0% | -0.68% | – |
| SGNT | Exit | SAGENT PHARMACEUTI | $0 | – | -1,008,265 | -100.0% | -1.56% | – |
| MYL | Exit | MYLAN N V | $0 | – | -408,170 | -100.0% | -1.82% | – |
| UNH | Exit | UNITEDHEALTH GRP INC | $0 | – | -145,095 | -100.0% | -2.12% | – |
| ALXN | Exit | ALEXION PHARM INC | $0 | – | -251,348 | -100.0% | -3.03% | – |
| ADPTQ | Exit | ADEPTUS HEALTH INCcl a | $0 | – | -619,108 | -100.0% | -3.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.